Article Sidebar

Download
PDF
Statistic
Read Counter : 127 Download : 27

Downloads

Download data is not yet available.

Main Article Content

Abstract

Prostate cancer is globally the second most common malignancy and the sixth leading cause of cancer-related death in men. The growing elderly population in Banjarbaru City, South Kalimantan, further elevates the risk of prostate cancer incidence in the region. Therefore, this community service initiative aimed to improve the knowledge and skills of healthcare professionals serving the elderly within the working area of the Banjarbaru City Health Office in early detection and prevention of prostate cancer. The activity was conducted as a comprehensive training involving 20 healthcare professionals, encompassing both theoretical and practical sessions. Training outcomes revealed a significant increase in participants' knowledge, evidenced by an average pre-test score of 55.91 which rose to an average post-test score of 84.35. Additionally, there was a noticeable improvement in healthcare professionals' skills in performing early detection and preventive measures for prostate cancer. Overall, this training successfully enhanced the capacity of healthcare professionals in Banjarbaru City in the early management of prostate cancer.

Keywords

Early detection Prostate cancer Healthcare professionals Elderly men Health education

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author Biographies

Eka Yudha Rahman, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Bedah

Roselina Panghiyangani, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Biomedik

Nia Kania, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Patologi Anatomi

Hendra Sutapa, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Bedah

Deddy Rasyidan Yulizar, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Bedah

Winardi Budiwinata, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Bedah

Nika Sterina Skripsiana, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Departemen Ilmu Kesehatan Masyarakat

M. Fathur Rachman, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Program Studi Kedokteran Program Sarjana

Gusti Dicky Fatharoni, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Program Studi Kedokteran Program Sarjana

Fahdyanoor Fahdyanoor, Universitas Lambung Mangkurat, Banjarmasin, Indonesia

Program Studi Kedokteran Program Sarjana

References

  1. Afriansyah, A., Hamid, A. R. A. H., Mochtar, C. A., & Umbas, H. R. (2019). Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia. International Journal of Urology, 26(1), 83–89. https://doi.org/10.1111/iju.13813
  2. Akram, O. N., Mushtaq, G., & Kamal, M. A. (2015). An overview of current screening and management approaches for prostate cancer. Current Drug Metabolism, 16(8), 713–718. https://doi.org/10.2174/1389200216666150812122430
  3. Ati, V. R. B. (2021). Faktor- faktor Risiko Yang Berhubungan Dengan Kejadian Kanker Prostat (Studi Kasus Di RSUD Prof. Dr. Margono Soekarjo Purwokerto) Risk Factors Assciated With The Event Of Prostate Cancer (Case Study in Prof. Dr. Margono Soekarjo Purwokerto Hospital). Mandala of Health: A Scientific Journal, 14(2), 67–73. https://doi.org/10.20884/1.mandala.2021.14.2.5116
  4. Badan Pusat Statistik. (2024). Angka Harapan Hidup (AHH) Menurut Provinsi dan Jenis Kelamin (Tahun).
  5. Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., Bray, F., Brawley, O., Luckenbaugh, A. N., Mucci, L., Morgan, T. M., & Carlsson, S. V. (2023). 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review. European Urology, 84(2), 191–206. https://doi.org/10.1016/j.eururo.2023.04.021
  6. Beyer, K., Leenen, R., Venderbos, L. D. F., Helleman, J., Denijs, F., Bramer, W., Vasilyeva, V., Briers, E., Rivas, J. G., Chloupkova, R., Majek, O., Annemans, L., Vynckier, P., Basu, P., Chandran, A., van den Bergh, R., Collen, S., van Poppel, H., & Roobol, M. J. (2024). Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium. Journal of Personalized Medicine, 14(1). https://doi.org/10.3390/jpm14010084
  7. Brawley, O. W. (2012). Prostate cancer epidemiology in the United States. World Journal of Urology, 30(2), 195–200. https://doi.org/10.1007/s00345-012-0824-2
  8. Chodak, G. W. (2016). Prostate Cancer.
  9. Cussenot, O., Renard-Penna, R., Montagne, S., Ondet, V., Pilon, A., Guechot, J., Comperat, E., Hamdy, F., Lamb, A., & Cancel-Tassin, G. (2023). Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk. BJU International, 131(6), 745–754. https://doi.org/10.1111/bju.15968
  10. Diaz, G. M., Webb, L. T., Rabil, M. J., Lokeshwar, S. D., Choksi, A. U., Leapman, M. S., & Sprenkle, P. C. (2024). Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. Current Urology Reports, 25(10), 243–252. https://doi.org/10.1007/s11934-024-01220-w
  11. Dinas Kesehatan Kota Banjarbaru. (2023a). Data Penduduk Sasaran Program Kesehatan Kota Banjarbaru.
  12. Dinas Kesehatan Kota Banjarbaru. (2023b). Profil Dinas Kesehatan Kota Banjarbaru.
  13. Kimura, T., & Egawa, S. (2018). Epidemiology of prostate cancer in Asian countries. International Journal of Urology, 25(6), 524–531. https://doi.org/10.1111/iju.13593
  14. Kuru, M., Talat, Z., Sağer, M. S., & Demirdağ, Ç. (2020). Technetium-99m-MIBI-SPECT for prostate cancer diagnosis. Ukrainian Journal of Nephrology and Dialysis, 2020(1), 20–28. https://doi.org/10.31450/ukrjnd.1(65).2020.04
  15. Loeb, S., & Schaeffer, E. M. (2009). Risk Factors, Prevention and Early Detection of Prostate Cancer. Primary Care - Clinics in Office Practice, 36(3), 603–621. https://doi.org/10.1016/j.pop.2009.04.007
  16. Merriel, S. W. D., Funston, G., & Hamilton, W. (2018). Prostate Cancer in Primary Care. Advances in Therapy, 35(9), 1285–1294. https://doi.org/10.1007/s12325-018-0766-1
  17. Roberth, J. I., Siagian, J. W., Jayadi, T., & Hariatmoko. (2022). Hubungan Usia dengan Benign Prostate Hyperplasia dan Adenokarsinoma Prostat di Rumah Sakit Bethesda Yogyakarta. Jurnal MedScientiae, 1(2), 6–11. https://doi.org/10.36452/jmedscientiae.v1i2.2549
  18. Roestijawati, N. (2016). Hubungan Kadar Kadmium Darah Dengan Karsinogenesis Prostat: Studi Kadar PSA, IGF-1 dan Polimorfisme Gen PSA rs266882 Pada Kelompok Terpapar Cd. Dissertation, Universitas Gadjah Mada Yogyakarta.
  19. Safriadi, F., Umbas, H. R., Hakim, L., Warli, S. M., Hamid, A. R., Hudaya, S., Ismy, J., Soerohardjo, I., Widjanarko, S., & Yudiana, W. (2022). Panduan Penanganan Kanker Prostat 2022. Ikatan Ahli Urologi Indonesia.
  20. Saputra, M. A. R., & Mahartono. (2016). Pria 39 Tahun Dengan Kanker Prostat Resisten Kastrasi Yang Bermetastasis ke Tulang. Jurnal Medula Unila, 4, 93–98.
  21. Sharma, M., Lawson, J., Karunanayake, C., Dosman, J., & Punam, P. (2016). Prostate Cancer, Farming and Other Risk Factors: A Mini Review. Journal of Prostate Cancer, 2(2), 1–5.
  22. Shieh, A. C., Guler, E., Ojili, V., Paspulati, R. M., Elliott, R., Ramaiya, N. H., & Tirumani, S. H. (2020). Extraprostatic extension in prostate cancer: primer for radiologists. Abdominal Radiology, 45(12), 4040–4051. https://doi.org/10.1007/s00261-020-02555-x
  23. Solang, V. R., Monoarfa, A., & Tjandra, F. (2016). Profil penderita kanker prostat di RSUP Prof. Dr. RD Kandou Manado periode tahun 2013-2015. Jurnal E-CliniC, 4(2). https://doi.org/10.35790/ecl.v4i2.14371
  24. Stephenson, A. J., & Klein, E. A. (2016). Epidemiology, etiology, and prevention of prostate cancer (A. Wein, L. Kavoussi, A. Partin, C. Peters, & A. Novick (eds.); 11th ed.). Campbell-Walsh Urology.
  25. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
  26. Suryadi, S. (2018). Dampak Peningkatan Usia Harapan Hidup Penduduk Indonesia terhadap Struktur Demografi dan Perawatan Lanjut Usia. Empower: Jurnal Pengembangan Masyarakat Islam, 3(2), 143–156. https://doi.org/10.24235/empower.v3i2.3515
  27. Turkbey, B., Brown, A. M., Sankineni, S., Wood, B. J., Pinto, P. A., & Choyke, P. L. (2016). Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer Journal for Clinicians, 66(4), 326–336. https://doi.org/10.3322/caac.21333
  28. Umbas, H. R., Safriadi, F., Danarto, H. R., Hakim, L., & Warli, S. M. (2023). Panduan Penanganan Kanker Prostat. Ikatan Ahli Urologi Indonesia (IAUI).
  29. Umbas, H. R., Safriadi, F., Mochtar, C. A., Djatisoesanto, W., & Hamid, A. R. A. H. (2015). Urologic cancer in Indonesia. Japanese Journal of Clinical Oncology, 45(8), 708–712. https://doi.org/10.1093/jjco/hyv066
  30. Wei, J. T., Barocas, D., Carlsson, S., Coakley, F., Eggener, S., Etzioni, R., Fine, S. W., Han, M., Kim, S. K., Kirkby, E., Konety, B. R., Miner, M., Moses, K., Nissenberg, M. G., Pinto, P. A., Salami, S. S., Souter, L., Thompson, I. M., & Lin, D. W. (2023). Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. Journal of Urology, 210(1), 46–53. https://doi.org/10.1097/JU.0000000000003491
  31. Wilbur, J. (2008). Prostate cancer screening: The continuing controversy. American Family Physician, 78(12), 1377–1384.